Oct 17 (Reuters) - The U.S. Food and Drug Administration has approved Amgen (AMGN.O), opens new tab and AstraZeneca's (AZN.L), opens new tab drug for a type of chronic inflammatory sinus disease, the ...

Dear Doctors: My nose has been plugged up for a few weeks from a sinus infection. Now my left ear is feeling full, and sounds are muffled. Can that be related? My dad says yes. (He has GERD, and he ...

Upstream Bio shares rose after the biotechnology company reported positive results for a trial of a sinus-disease treatment. The stock advanced 7.1% to $18.34 on Tuesday. Shares have gained 12% this ...

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by University College London (UCL) along with academics at the University ...

THE purpose of this paper is to review the recent trends in the control of acute bacterial infections of the frontal sinus consequent to the impact on therapeutic concepts of the bacteriostatic and ...

Sarah Hudgens is a content pro with over 15 years of experience writing and editing copy for a wide range of industry verticals and channels. Allergic rhinitis (allergies or hay fever) and sinusitis ...

DEAR MAYO CLINIC: Ever since I turned 30, I’ve been having painful headaches frequently. My sister gets sinus infections all the time, but my mom had migraines at my age. How do I know what I’m ...

A sinus infection (sinusitis) is caused by a virus or (sometimes) bacteria that creates swelling in the nasal passages. Oftentimes, sinus infections come with or after a viral upper respiratory ...

GSK's Nucala approved in China for CRSwNP, affecting 1/3 of 107 million sinusitis patients; third IL-5 condition indication in the region. Phase 3 trial shows Nucala reduces COPD exacerbations; FDA ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on therapy with intranasal corticosteroids for adult patients with chronic ...

Search for other works by this author on: New growths originating in the cranial bones are uncommon, although the skull may be affected secondarily by benign or malignant conditions arising in other ...